-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U8lT2ywgZtVmIE7wekDLiWyN/mDfYIWxt7xCFEKYRHwluFivq+W/IpctL6X//bq2 Lu2HKB56tUYwDQ6ReWf+/Q== 0000893949-07-000008.txt : 20070810 0000893949-07-000008.hdr.sgml : 20070810 20070810191324 ACCESSION NUMBER: 0000893949-07-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070808 FILED AS OF DATE: 20070810 DATE AS OF CHANGE: 20070810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 650271219 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEDEL ROGER MD CENTRAL INDEX KEY: 0001093125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 071046809 MAIL ADDRESS: STREET 1: 1455 NORTH PARK DRIVE CITY: FORT LAUDERDALE STATE: FL ZIP: 33326 4 1 doc.xml PRIMARY DOCUMENT X0202 4 2007-08-08 0000893949 PEDIATRIX MEDICAL GROUP INC PDX 0001093125 MEDEL ROGER MD 1301 CONCORD TERRACE SUNRISE FL 33323-2825 1 1 0 0 CHIEF EXECUTIVE OFFICER Common Stock 87499 D Common Stock 480 I BY CHILD Common Stock 2007-08-08 4 M 0 100000 22.56 A 100000 I BY SPOUSE Common Stock 2007-08-08 4 S 0 80000 57.71 D 20000 I BY SPOUSE Common Stock 2007-08-09 4 S 0 20000 56.45 D 0 I BY SPOUSE Stock Option 22.5625 2007-08-08 4 M 0 100000 0 D 2002-03-26 2008-10-29 Common Stock 100000 0 I BY SPOUSE This sale has been executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective February 9, 2004. The sale of shares was executed in fifty-one (51) separate transactions with sales prices ranging from $55.93 to $57.33 for a weighted average sales price of $56.45. These stock options were granted under the Issuer's Amended and Restated Stock Option Plan. The sale of shares was executed in ninety-eight (98) separate transactions with sales prices ranging from $56.25 to $58.00 for a weighted average sales price of $57.71. These stock options were granted under the Issuer's Amended and Restated Stock Option Plan and became exercisable in three equal increments on March 26, 2000, 2001 and 2002. By: Thomas W. Hawkins 2007-08-10 -----END PRIVACY-ENHANCED MESSAGE-----